Literature DB >> 9143471

Structural modification of receptor-binding technetium-99m complexes in order to improve brain uptake.

B Johannsen1, R Berger, P Brust, H J Pietzsch, M Scheunemann, S Seifert, H Spies, R Syhre.   

Abstract

Low brain uptake is a generally accepted problem in developing technetium-99m brain receptor imaging agents. For a class of potential 5-HT2A receptor-binding agents we tried to improve the original low brain uptake of 0.4% injected dose (ID) in rats 5 min p.i. by modifying the lipophilic properties of the molecules. Because of the presence of a protonable nitrogen, which according to the pKa value leads to ionization of the molecule at blood pH, the pKa value was considered to be the parameter most suitable for adjustment of lipophilicity. Insertion of ether-oxygen in the molecule of five candidates lowers the apparent pKa value from 10.0 to 8.3 and dramatically increases the brain uptake to 1.3% ID at 5 min. The direct relationship between brain uptake and apparent pKa cannot be simply explained by the increase in the pKa-governed proportion of the neutral species.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9143471     DOI: 10.1007/bf01728770

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  2 in total

1.  Permeation studies in vitro and in vivo of potential radiopharmaceuticals with affinity to neuro receptors.

Authors:  M Friebe; K Suda; H Spies; R Syhre; R Berger; B Johannsen; E Chiotellis; S D Krämer; H Wunderli-Allenspach
Journal:  Pharm Res       Date:  2000-06       Impact factor: 4.200

2.  Synthesis and biological evaluation of new [Tc(N)(PS)]-based mixed-ligand compounds useful in the design of target-specific radiopharmaceuticals: the 2-methoxyphenylpiperazine dithiocarbamate derivatives as an example.

Authors:  Cristina Bolzati; Nicola Salvarese; Davide Carta; Fiorenzo Refosco; Alessandro Dolmella; Hans Jürgen Pietzsch; Ralf Bergmann; Giuliano Bandoli
Journal:  J Biol Inorg Chem       Date:  2010-10-07       Impact factor: 3.358

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.